Fidelity Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-467,573
Closed -$31.8M 5704
2022
Q3
$31.8M Sell
467,573
-2,614,144
-85% -$178M ﹤0.01% 1430
2022
Q2
$98.5M Sell
3,081,717
-1,009,982
-25% -$32.3M 0.01% 979
2022
Q1
$142M Sell
4,091,699
-190,702
-4% -$6.61M 0.01% 923
2021
Q4
$125M Buy
4,282,401
+1,276,350
+42% +$37.4M 0.01% 1007
2021
Q3
$76.6M Buy
3,006,051
+1,561,094
+108% +$39.8M 0.01% 1224
2021
Q2
$50.6M Sell
1,444,957
-1,466,007
-50% -$51.3M ﹤0.01% 1423
2021
Q1
$119M Sell
2,910,964
-1,496,101
-34% -$61M 0.01% 997
2020
Q4
$191M Sell
4,407,065
-2,253,143
-34% -$97.6M 0.02% 762
2020
Q3
$367M Sell
6,660,208
-2,480,246
-27% -$137M 0.04% 411
2020
Q2
$577M Buy
9,140,454
+772,248
+9% +$48.8M 0.06% 276
2020
Q1
$428M Buy
8,368,206
+3,131,851
+60% +$160M 0.06% 285
2019
Q4
$416M Sell
5,236,355
-855,714
-14% -$68M 0.05% 380
2019
Q3
$296M Sell
6,092,069
-1,832,916
-23% -$88.9M 0.04% 475
2019
Q2
$417M Sell
7,924,985
-492,724
-6% -$25.9M 0.05% 378
2019
Q1
$446M Buy
8,417,709
+88,310
+1% +$4.67M 0.05% 343
2018
Q4
$342M Buy
8,329,399
+521,563
+7% +$21.4M 0.05% 391
2018
Q3
$297M Buy
7,807,836
+1,357,642
+21% +$51.6M 0.03% 516
2018
Q2
$292M Sell
6,450,194
-767,345
-11% -$34.7M 0.03% 508
2018
Q1
$349M Buy
7,217,539
+1,633,486
+29% +$78.9M 0.04% 464
2017
Q4
$220M Buy
5,584,053
+357,122
+7% +$14.1M 0.03% 650
2017
Q3
$162M Sell
5,226,931
-164,719
-3% -$5.11M 0.02% 766
2017
Q2
$147M Sell
5,391,650
-367,821
-6% -$10.1M 0.02% 804
2017
Q1
$212M Buy
5,759,471
+162,004
+3% +$5.97M 0.03% 668
2016
Q4
$80.9M Buy
5,597,467
+4,656
+0.1% +$67.3K 0.01% 1100
2016
Q3
$129M Buy
5,592,811
+59,350
+1% +$1.37M 0.02% 859
2016
Q2
$91.8M Buy
5,533,461
+959,169
+21% +$15.9M 0.01% 1018
2016
Q1
$72.5M Buy
4,574,292
+5,730
+0.1% +$90.9K 0.01% 1107
2015
Q4
$148M Buy
4,568,562
+154,129
+3% +$4.98M 0.02% 794
2015
Q3
$186M Buy
+4,414,433
New +$186M 0.03% 664